Private company
ISTA Pharmaceuticals
Logo: ISTA Pharmaceuticals, Inc, PD, via Wikipedia3
US-based pharmaceutical company
ISTA Pharmaceuticals, Inc., was a US-based pharmaceutical company that specialized in ophthalmic pharmaceutical products and discovers, develops, and markets therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. ISTA was acquired by Bausch & Lomb, an eye care company, on March 26, 2012. Under the deal, Bausch & Lomb have agreed to pay $9.10 per share for ISTA, bringing the total value of the acquisition to $500 million.2 It is headquartered in Irvine.1 Wikipedia text CC BY-SA 4.0
Last updated Oct 21, 2026.
Overview
See how the biggest companies compare on our leaderboards
ISTA Pharmaceuticals, Inc., was a US-based pharmaceutical company that specialized in ophthalmic pharmaceutical products and discovers, develops, and markets therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. ISTA was acquired by Bausch & Lomb, an eye care company, on March 26, 2012. Under the deal, Bausch & Lomb have agreed to pay $9.10 per share for ISTA, bringing the total value of the acquisition to $500 million. In 2012, Valeant Pharmaceuticals withdrew its $360 million offer.2
Products and brands
- bromfenac
Listed on Wikidata.1
Bromday (bromfenac ophthalmic solution) 0.09% for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction
Bepreve (bepotastine besilate ophthalmic solution) 1.5% for the treatment of itching associated with signs and symptoms of allergic conjunctivitis
Xibrom (bromfenac ophthalmic solution) 0.09% for the treatment of inflammation and pain following cataract surgery (no longer being manufactured as of February 2011)
Istalol (timolol maleate ophthalmic solution) 0.5% for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma
Read the full text
Vitrase (hyaluronidase injection) Ovine, 200 USP units/mL for use as an adjuvant to increase the absorption and dispersion of other injected drugs; for hypodermoclysis; and as an adjunct in subcutaneous urography for improving resorption of radiopaque agents
From Wikipedia’s article on ISTA Pharmaceuticals, shared under CC BY-SA 4.0.4
Controversies and legal
Litigation
On May 24, 2013, ISTA Pharmaceuticals entered a guilty plea to federal felony charge of conspiracy to introduce a misbranded drug into interstate commerce and conspiracy to pay illegal remuneration in violation of the Federal Anti-Kickback Statute. ISTA agreed to pay $33.5 million to resolve criminal and civil liability arising from its marketing, distribution and sale of its drug Xibrom.
From Wikipedia’s article on ISTA Pharmaceuticals, shared under CC BY-SA 4.0.4
Timeline
- 1992Founded Founded1
Links
- WikipediaISTA Pharmaceuticals
- WikidataQ5974522
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataISTA Pharmaceuticals on Wikidata
- 2WikipediaISTA Pharmaceuticals on Wikipedia
- 3Wikimedia CommonsISTA Pharmaceuticals logo by ISTA Pharmaceuticals, Inc, PD
- 4